Health - Google News: Onyx, Astellas say liver drug combination fails

Monday, July 23, 2012

Health - Google News

Google News

Jul 23rd 2012, 15:07

Onyx, Astellas say liver drug combination fails
CBS News
NEW YORK — A group of three drugmakers said Monday that a combination of their cancer pills Tarceva and Nexavar did not meet their main goal in a late-stage clinical trial. Onyx Pharmaceuticals Inc., Bayer AG, and Astellas Pharma Inc. said patients who ...
Nexavar fails combo trial, but keeps liver cancer crownFiercePharma
Bayer Says Phase III Tarceva-Nexavar Study Fails - Quick FactsRTT News
Bayer, Onyx, Astellas report Phase 3 HCC trial resultsPharmaceutical Business Review
WKZO -NASDAQ
all 37 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in:

Paparazziii